Zimmer Biomet Holdings, Inc.
ZIM.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.25B
Close$
Share Statistics
| Market cap | $17.25 Billion |
|---|---|
| Enterprise Value | $24.31 Billion |
| Dividend Yield | $0.83 (1.08%) |
| Earnings per Share | $3.56 |
| Beta | 1.35 |
| Outstanding Shares | 195,000,000 |
Return
| Return on Equity | 6.39% |
|---|---|
| Return on Assets | 3.54% |
| Return on Invested Capital | 6.81% |
Valuation & Multiples
| P/E Ratio | 21.58 |
|---|---|
| PEG | - |
| Price to Sales | 2.21 |
| Price to Book Ratio | 1.48 |
| Enterprise Value to Revenue | 2.86 |
| Enterprise Value to EBIT | 18.06 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$1.76
Average shareholder expectationRevenue Estimate
$1.87 B
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$1.63
Average shareholder expectationRevenue Estimate
$1.77 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zimmer Biomet Holdings Inc
17,000 employees
CEO: Bryan Hanson Zimmer Biomet Holdings, Inc., along with its various subsidiaries, is a prominent player in the global musculoskeletal healthcare industry, providing its specialized solutions across the Americas, Europe, the Middle East, Africa, and the...